[HTML][HTML] A review for the neuroprotective effects of andrographolide in the central nervous system

J Lu, Y Ma, J Wu, H Huang, X Wang, Z Chen… - Biomedicine & …, 2019 - Elsevier
Andrographolide is compound extracted from Andrographis paniculata (A. paniculata), a
traditional herb that has been used in ancient China and other parts of eastern Asia to treat …

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection

Y Du, J Wu, J Liu, X Zheng, D Yang, M Lu - Frontiers in Immunology, 2022 - frontiersin.org
Chronic hepatitis B virus (HBV) infection remains to be a substantial global burden,
especially for end-stage liver diseases. It is well accepted that HBV-specific T and B cells are …

[HTML][HTML] Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells

AH Mooney, SL Draper, OK Burn, RJ Anderson… - JHEP Reports, 2024 - Elsevier
Abstract Background & Aims Liver diseases resulting from chronic HBV infection are a
significant cause of morbidity and mortality. Vaccines that elicit T-cell responses capable of …

Opportunities for conventional and in situ cancer vaccine strategies and combination with immunotherapy for gastrointestinal cancers, a review

R Bouzid, M Peppelenbosch, SI Buschow - Cancers, 2020 - mdpi.com
Survival of gastrointestinal cancer remains dismal, especially for metastasized disease. For
various cancers, especially melanoma and lung cancer, immunotherapy has been proven to …

[HTML][HTML] Peptides to combat viral infectious diseases

S Al-Azzam, Y Ding, J Liu, P Pandya, JP Ting, S Afshar - Peptides, 2020 - Elsevier
Viral infectious diseases have resulted in millions of deaths throughout history and have
created a significant public healthcare burden. Tremendous efforts have been placed by the …

[HTML][HTML] Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma

MTA de Beijer, K Bezstarosti, R Luijten, WAS Doff… - JHEP Reports, 2022 - Elsevier
Background & Aims Antigen-specific immunotherapy is a promising strategy to treat HBV
infection and hepatocellular carcinoma (HCC). To facilitate killing of malignant and/or …

Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo

DTSL Jansen, MTA de Beijer, RJ Luijten… - Frontiers in …, 2023 - frontiersin.org
Introduction Therapeutic vaccination based on synthetic long peptides (SLP®) containing
both CD4+ and CD8+ T cell epitopes is a promising treatment strategy for chronic hepatitis B …

HLA I immunopeptidome of synthetic long peptide pulsed human dendritic cells for therapeutic vaccine design

AL Kessler, RFA Pieterman, WAS Doff, K Bezstarosti… - npj Vaccines, 2025 - nature.com
Synthetic long peptides (SLPs) are a promising vaccine modality that exploit dendritic cells
(DC) to treat chronic infections or cancer. Currently, the design of SLPs relies on in silico …

Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere–Encapsulated Antigen and a Synthetic Long Peptide In Vitro

EGM Tondeur, JSA Voerman… - The Journal of …, 2023 - journals.aai.org
The induction of CTL responses by vaccines is important to combat infectious diseases and
cancer. Biodegradable poly (lactic-co-glycolic acid)(PLGA) microspheres and synthetic long …

Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures

DTSL Jansen, Y Dou, JW de Wilde… - Clinical & …, 2021 - Wiley Online Library
In the mid‐90s, hepatitis B virus (HBV)‐directed immune responses were for the first time
investigated in detail and revealed suboptimal T‐cell responses in chronic HBV patients …